Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 4550 | 1693 | 32.5 | 66% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | THROMBOXANE A2 RECEPTOR | Author keyword | 54 | 64% | 3% | 53 |
| 2 | THROMBOXANE RECEPTOR | Author keyword | 26 | 52% | 2% | 35 |
| 3 | THROMBOXANE A2 | Author keyword | 25 | 17% | 8% | 138 |
| 4 | S 1452 | Author keyword | 21 | 85% | 1% | 11 |
| 5 | THROMBOXANE A2 RECEPTOR ANTAGONISTS | Author keyword | 12 | 86% | 0% | 6 |
| 6 | PICOTAMIDE | Author keyword | 12 | 59% | 1% | 13 |
| 7 | THROMBOXANE A2 RECEPTORS | Author keyword | 11 | 67% | 1% | 10 |
| 8 | THROMBOXANE RECEPTOR ANTAGONIST | Author keyword | 10 | 47% | 1% | 16 |
| 9 | THROMBOXANE ANTAGONISTS | Author keyword | 10 | 63% | 1% | 10 |
| 10 | THROMBOXANE A2 RECEPTOR ANTAGONIST | Author keyword | 9 | 47% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | THROMBOXANE A2 RECEPTOR | 54 | 64% | 3% | 53 | Search THROMBOXANE+A2+RECEPTOR | Search THROMBOXANE+A2+RECEPTOR |
| 2 | THROMBOXANE RECEPTOR | 26 | 52% | 2% | 35 | Search THROMBOXANE+RECEPTOR | Search THROMBOXANE+RECEPTOR |
| 3 | THROMBOXANE A2 | 25 | 17% | 8% | 138 | Search THROMBOXANE+A2 | Search THROMBOXANE+A2 |
| 4 | S 1452 | 21 | 85% | 1% | 11 | Search S+1452 | Search S+1452 |
| 5 | THROMBOXANE A2 RECEPTOR ANTAGONISTS | 12 | 86% | 0% | 6 | Search THROMBOXANE+A2++RECEPTOR+ANTAGONISTS | Search THROMBOXANE+A2++RECEPTOR+ANTAGONISTS |
| 6 | PICOTAMIDE | 12 | 59% | 1% | 13 | Search PICOTAMIDE | Search PICOTAMIDE |
| 7 | THROMBOXANE A2 RECEPTORS | 11 | 67% | 1% | 10 | Search THROMBOXANE+A2+RECEPTORS | Search THROMBOXANE+A2+RECEPTORS |
| 8 | THROMBOXANE RECEPTOR ANTAGONIST | 10 | 47% | 1% | 16 | Search THROMBOXANE+RECEPTOR+ANTAGONIST | Search THROMBOXANE+RECEPTOR+ANTAGONIST |
| 9 | THROMBOXANE ANTAGONISTS | 10 | 63% | 1% | 10 | Search THROMBOXANE+ANTAGONISTS | Search THROMBOXANE+ANTAGONISTS |
| 10 | THROMBOXANE A2 RECEPTOR ANTAGONIST | 9 | 47% | 1% | 14 | Search THROMBOXANE+A2+RECEPTOR+ANTAGONIST | Search THROMBOXANE+A2+RECEPTOR+ANTAGONIST |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | A2 RECEPTOR | 39 | 46% | 4% | 64 |
| 2 | ENDOPEROXIDE RECEPTOR | 27 | 92% | 1% | 11 |
| 3 | TP ALPHA | 23 | 79% | 1% | 15 |
| 4 | SQ 29 548 | 23 | 65% | 1% | 22 |
| 5 | AA 2414 | 21 | 90% | 1% | 9 |
| 6 | SYNTHETASE INHIBITOR | 20 | 33% | 3% | 49 |
| 7 | PROSTAGLANDIN H2 RECEPTORS | 18 | 89% | 0% | 8 |
| 8 | S 145 | 18 | 89% | 0% | 8 |
| 9 | PROSTAGLANDIN ENDOPEROXIDES | 16 | 18% | 5% | 81 |
| 10 | 13 AZAPROSTANOIC ACID | 15 | 82% | 1% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology | 2008 | 144 | 194 | 64% |
| Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation | 2014 | 8 | 96 | 38% |
| Thromboxane A(2) Receptor: Biology and Function of a Peculiar Receptor that Remains Resistant for Therapeutic Targeting | 2012 | 7 | 123 | 54% |
| From the design to the clinical application of thromboxane modulators | 2006 | 36 | 242 | 48% |
| Thromboxane A(2) and related prostaglandins in airways | 1997 | 49 | 155 | 47% |
| The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis | 2011 | 22 | 99 | 44% |
| Cell signalling through thromboxane A(2) receptors | 2004 | 93 | 194 | 44% |
| Prostanoid and TP-receptors in atherothrombosis Is there a role for their antagonism? | 2010 | 21 | 58 | 43% |
| Therapeutic potential of thromboxane inhibitors in asthma | 2002 | 22 | 72 | 68% |
| Thromboxanes: Synthase and receptors | 1998 | 54 | 163 | 49% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INFLAMMAT PHARMACOL S | 3 | 38% | 0.4% | 6 |
| 2 | CELL MOLEC PHARMACOL EXPTL THER EUT | 2 | 67% | 0.1% | 2 |
| 3 | NAT SYNTH DRUG | 2 | 40% | 0.2% | 4 |
| 4 | 171 ASHLEY AVE | 1 | 50% | 0.1% | 2 |
| 5 | EXPT HEMODYNAM HEMOLIEGE | 1 | 100% | 0.1% | 2 |
| 6 | KLINIKUM MANNHEIM CLIN CHEM | 1 | 100% | 0.1% | 2 |
| 7 | PHARMACOL 171 ASHLEY AVE | 1 | 50% | 0.1% | 2 |
| 8 | PMS PLANNING DEV GRP | 1 | 100% | 0.1% | 2 |
| 9 | POB 1005 | 1 | 100% | 0.1% | 2 |
| 10 | NAT SYNTHET DRUG | 1 | 27% | 0.2% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000221732 | EXPT THER EUT PHARMACOINFORMAT//PROSTACYCLIN SYNTHASE GENE//PROSTACYCLIN SYNTHASE |
| 2 | 0.0000157001 | ILOPROST//WESTERN INFIRM SURG//TAPROSTENE |
| 3 | 0.0000124276 | ONO 1301//IP RECEPTOR//EP4 RECEPTOR |
| 4 | 0.0000101025 | 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT |
| 5 | 0.0000078531 | MED BIOCHEM KURAMOTO CHO//4 ACETOXY 2 4 METHYLPHENYLBENZOTHIAZOLE//PHARMACEUT S KITA KU |
| 6 | 0.0000076012 | ENDOTHELIUM DEPENDENT CONTRACTIONS//ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR |
| 7 | 0.0000074746 | HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2 |
| 8 | 0.0000065233 | CARBACYCLIN//CARBACYCLINS//SM 10906 |
| 9 | 0.0000062273 | CRTH2//MOL BEHAV BIOL//PROSTAGLANDIN D 2 |
| 10 | 0.0000060050 | AGGREGATED PROTEIN//IMMUNOGLOBULIN G COMPLEXES//MESANGIUM |